165 related articles for article (PubMed ID: 22928961)
1. Successful haploidentical PBSCT with subsequent T-cell addbacks in a boy with HyperIgM syndrome presenting as severe congenital neutropenia.
Jasinska A; Kalwak K; Trelinska J; Borowiec M; Piatosa B; Zeman K; Mlynarski W
Pediatr Transplant; 2013 Feb; 17(1):E37-40. PubMed ID: 22928961
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell transplantation for hyper-IgM syndromes.
Rezaei N; Notarangelo LD
Pediatr Transplant; 2013 Feb; 17(1):1-2. PubMed ID: 23078614
[No Abstract] [Full Text] [Related]
3. Severe congenital neutropenia or hyper-IgM syndrome? A novel mutation of CD40 ligand in a patient with severe neutropenia.
Rezaei N; Aghamohammadi A; Ramyar A; Pan-Hammarstrom Q; Hammarstrom L
Int Arch Allergy Immunol; 2008; 147(3):255-9. PubMed ID: 18594157
[TBL] [Abstract][Full Text] [Related]
4. Heterozygous M1V variant of ELA-2 gene mutation associated with G-CSF refractory severe congenital neutropenia.
Setty BA; Yeager ND; Bajwa RP
Pediatr Blood Cancer; 2011 Sep; 57(3):514-5. PubMed ID: 21618407
[TBL] [Abstract][Full Text] [Related]
5. The polymorphism p.G219R of CD40L does not cause immunological alterations in vivo: conclusions from a X-linked hyper IgM syndrome kindred.
Martinez-Martinez L; Gonzalez-Santesteban C; Badell I; de la Calle-Martin O
Mol Immunol; 2012 Oct; 52(3-4):237-41. PubMed ID: 22750225
[TBL] [Abstract][Full Text] [Related]
6. De novo mutation causing X-linked hyper-IgM syndrome: a family study in Taiwan.
Ma YC; Lee WI; Shyur SD; Lin SC; Huang LH; Wu JY
Asian Pac J Allergy Immunol; 2005 Mar; 23(1):53-9. PubMed ID: 15997875
[TBL] [Abstract][Full Text] [Related]
7. [Unrelated umbilical cord blood stem cell transplantation in the treatment of hyper-IgM syndrome caused by CD40 ligand gene mutation: a report of three cases and literature review].
Wang P; Qian XW; Wang HS; Jiang WJ; Sun JQ; Wang XC; Zhai XW
Zhonghua Er Ke Za Zhi; 2021 Oct; 59(10):830-835. PubMed ID: 34587678
[No Abstract] [Full Text] [Related]
8. The usefulness of X-linked polymorphic loci as gene markers to track X allele and chimerism in a post-allogeneic peripheral blood stem cell transplant patient with Wiskott-Aldrich syndrome.
Sasanakul W; Hongeng S; Chuansumrit A; Chaiyaratana W; Pakakasama S; Hathirat P
J Med Assoc Thai; 2001 Mar; 84(3):379-84. PubMed ID: 11460939
[TBL] [Abstract][Full Text] [Related]
9. Hyper IgM Syndrome: a Report from the USIDNET Registry.
Leven EA; Maffucci P; Ochs HD; Scholl PR; Buckley RH; Fuleihan RL; Geha RS; Cunningham CK; Bonilla FA; Conley ME; Ferdman RM; Hernandez-Trujillo V; Puck JM; Sullivan K; Secord EA; Ramesh M; Cunningham-Rundles C
J Clin Immunol; 2016 Jul; 36(5):490-501. PubMed ID: 27189378
[TBL] [Abstract][Full Text] [Related]
10. Immunologic reconstitution following bone marrow transplantation for X-linked hyper IgM syndrome.
Duplantier JE; Seyama K; Day NK; Hitchcock R; Nelson RP; Ochs HD; Haraguchi S; Klemperer MR; Good RA
Clin Immunol; 2001 Mar; 98(3):313-8. PubMed ID: 11237554
[TBL] [Abstract][Full Text] [Related]
11. [Two children with severe recurrent infections and the X-linked hyper-IgM syndrome].
Groeneweg M; Hartwig NG; Poerink-Stockschläder AB; Schweizer JJ; Bijleveld CM; Bredius RG
Ned Tijdschr Geneeskd; 2003 May; 147(21):1024-8. PubMed ID: 12811975
[TBL] [Abstract][Full Text] [Related]
12. Correction of neutropenia and hypogammaglobulinemia in X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation.
Scholl PR; O'Gorman MR; Pachman LM; Haut P; Kletzel M
Bone Marrow Transplant; 1998 Dec; 22(12):1215-8. PubMed ID: 9894727
[TBL] [Abstract][Full Text] [Related]
13. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
Meng X; Yang B; Suen WC
Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
[TBL] [Abstract][Full Text] [Related]
14. X-linked hyper IgM syndrome: a novel sequence variant associated with an atypical mild phenotype.
Buchbinder D; Park S; Nugent D
J Pediatr Hematol Oncol; 2012 Jul; 34(5):e212-4. PubMed ID: 22322937
[TBL] [Abstract][Full Text] [Related]
15. Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.
Heinold A; Hanebeck B; Daniel V; Heyder J; Tran TH; Döhler B; Greil J; Müller FM
Infection; 2010 Dec; 38(6):491-6. PubMed ID: 20981468
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
[TBL] [Abstract][Full Text] [Related]
17. Hyper-IgM syndrome: report of one case.
Ma YC; Shyur SD; Huang LH; Wu JY; Lin SC
Acta Paediatr Taiwan; 2004; 45(6):334-9. PubMed ID: 15868849
[TBL] [Abstract][Full Text] [Related]
18. X-linked hyper-IgM syndrome with CD40LG mutation: two case reports and literature review in Taiwanese patients.
Tsai HY; Yu HH; Chien YH; Chu KH; Lau YL; Lee JH; Wang LC; Chiang BL; Yang YH
J Microbiol Immunol Infect; 2015 Feb; 48(1):113-8. PubMed ID: 23010537
[TBL] [Abstract][Full Text] [Related]
19. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F
Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
[TBL] [Abstract][Full Text] [Related]
20. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
